MedTrace Logo

Multiple-dose Nicotine Pharmacokinetics With Three Oral Nicotine Replacement Products

NCT01321931 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2012-07-10

No results posted yet for this study

Summary

Multiple-dose nicotine pharmacokinetics with three oral nicotine replacement products. A study in healthy smokers.

Conditions

  • Tobacco Dependence

Interventions

DRUG

Nicotine

6 mg experimental Nicotine Replacement Therapy (NRT)

DRUG

Nicotine

4 mg marketed Nicotine Fruit Gum (NFG)

DRUG

Nicotine

4 mg marketed nicotine mint lozenge (NIQ)

Sponsors & Collaborators

  • McNeil AB

    lead INDUSTRY

Principal Investigators

  • Elisabeth Kruse, PhD · McNeil AB

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2011-05-31
Completion
2011-06-30

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01321931 on ClinicalTrials.gov